EUCAST Technical Note on Aspergillus and amphotericin B, itraconazole, and posaconazole
- Arendrup, M.C.
- Cuenca-Estrella, M.
- Lass-Flörl, C.
- Hope, W.W.
Publication date
July 2012
DOI Publisher
European Society of Clinical Infectious Diseases. Published by Elsevier Ltd.Abstract
AbstractThe European Committee on Antimicrobial Susceptibility Testing Subcommittee on Antifungal Susceptibility Testing (EUCAST-AFST) has determined breakpoints for amphotericin B, itraconazole and posaconazole for Aspergillus species. This Technical Note is based on the EUCAST amphotericin B, itraconazole and posaconazole rationale documents (available on the EUCAST website: http://www.eucast.org/antifungal_susceptibility_testing_afst/rationale_documents_for_antifungals/). The amphotericin B and itraconazole breakpoints are based on epidemiological cut-off values and clinical experience. The posaconazole breakpoints are also based on pharmacokinetic and pharmacodynamic data. Breakpoints will be reviewed regularly or when new data emerge
Add to ORKG